1D1Z | pdb_00001d1z

CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP

External Resource: Annotation

Domain Annotation: SCOP/SCOPe Classification
Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
A	d1d1za_	Alpha and beta proteins (a+b)	SH2-like	SH2 domain	SH2 domain	The Xlp protein Sap	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
B	d1d1zb_	Alpha and beta proteins (a+b)	SH2-like	SH2 domain	SH2 domain	The Xlp protein Sap	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
C	d1d1zc_	Alpha and beta proteins (a+b)	SH2-like	SH2 domain	SH2 domain	The Xlp protein Sap	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
D	d1d1zd_	Alpha and beta proteins (a+b)	SH2-like	SH2 domain	SH2 domain	The Xlp protein Sap	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	SH2 domain	8035717	3000197	SCOP2B (2022-06-29)
B	SCOP2B Superfamily	SH2 domain	8035717	3000197	SCOP2B (2022-06-29)
C	SCOP2B Superfamily	SH2 domain	8035717	3000197	SCOP2B (2022-06-29)
D	SCOP2B Superfamily	SH2 domain	8035717	3000197	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	Anthrax_toxA	e1d1zA1	A: alpha bundles	X: EGF-like	H: LDL receptor-like module	T: LDL receptor-like module	F: Anthrax_toxA	ECOD (develop294)
B	Anthrax_toxA	e1d1zB1	A: alpha bundles	X: EGF-like	H: LDL receptor-like module	T: LDL receptor-like module	F: Anthrax_toxA	ECOD (develop294)
C	Anthrax_toxA	e1d1zC1	A: alpha bundles	X: EGF-like	H: LDL receptor-like module	T: LDL receptor-like module	F: Anthrax_toxA	ECOD (develop294)
D	Anthrax_toxA	e1d1zD1	A: alpha bundles	X: EGF-like	H: LDL receptor-like module	T: LDL receptor-like module	F: Anthrax_toxA	ECOD (develop294)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	3.30.505.10	Alpha Beta	2-Layer Sandwich	SHC Adaptor Protein	SH2 domain	CATH (4.3.0)
B	3.30.505.10	Alpha Beta	2-Layer Sandwich	SHC Adaptor Protein	SH2 domain	CATH (4.3.0)
C	3.30.505.10	Alpha Beta	2-Layer Sandwich	SHC Adaptor Protein	SH2 domain	CATH (4.3.0)
D	3.30.505.10	Alpha Beta	2-Layer Sandwich	SHC Adaptor Protein	SH2 domain	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D	PF00017	SH2 domain (SH2)	SH2 domain		Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	SAP SH2 DOMAIN	protein-macromolecule adaptor activity molecular adaptor activity	lymphocyte mediated immunity biological process involved in interspecies interaction between organisms response to stimulus immune response response to other organism defense response defense response to symbiont response to external stimulus leukocyte mediated cytotoxicity response to biotic stimulus immune effector process immune system process defense response to other organism response to stress natural killer cell mediated cytotoxicity lymphocyte mediated immunity biological process involved in interspecies interaction between organisms response to stimulus immune response response to other organism defense response defense response to symbiont response to external stimulus leukocyte mediated cytotoxicity response to biotic stimulus immune effector process immune system process defense response to other organism response to stress natural killer cell mediated cytotoxicity innate immune response leukocyte mediated immunity cellular process response to external biotic stimulus natural killer cell mediated immunity cell killing regulation of immune effector process positive regulation of leukocyte mediated immunity positive regulation of response to biotic stimulus regulation of cellular process positive regulation of leukocyte mediated cytotoxicity positive regulation of immune response positive regulation of natural killer cell mediated immunity regulation of immune system process positive regulation of immune system process regulation of biological process regulation of natural killer cell mediated immunity regulation of innate immune response regulation of leukocyte mediated immunity regulation of response to stimulus positive regulation of defense response regulation of immune response positive regulation of natural killer cell mediated cytotoxicity regulation of cell killing positive regulation of cell killing regulation of defense response regulation of response to biotic stimulus regulation of natural killer cell mediated cytotoxicity regulation of response to external stimulus positive regulation of lymphocyte mediated immunity positive regulation of biological process positive regulation of response to stimulus positive regulation of response to external stimulus regulation of response to stress positive regulation of immune effector process positive regulation of cellular process positive regulation of innate immune response regulation of leukocyte mediated cytotoxicity biological regulation regulation of lymphocyte mediated immunity cellular response to stimulus immune response-regulating cell surface receptor signaling pathway signaling negative regulation of signaling negative regulation of biological process regulation of signal transduction regulation of antigen receptor-mediated signaling pathway negative regulation of antigen receptor-mediated signaling pathway negative regulation of cell communication cell communication immune response-activating signaling pathway immune response-regulating signaling pathway negative regulation of cellular process signal transduction regulation of signaling cell surface receptor signaling pathway immune response-activating cell surface receptor signaling pathway negative regulation of response to stimulus regulation of T cell receptor signaling pathway T cell receptor signaling pathway negative regulation of signal transduction negative regulation of T cell receptor signaling pathway negative regulation of immune system process regulation of cell communication antigen receptor-mediated signaling pathway activation of immune response adaptive immune response multicellular organismal process cell activation natural killer cell activation lymphocyte activation leukocyte activation humoral immune response cellular defense response cell-cell signaling	cellular anatomical structure intracellular anatomical structure cytoplasm cytosol

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR036860	SH2 domain superfamily	Homologous Superfamily
A, B, C, D	IPR000980	SH2 domain	Domain
A, B, C, D	IPR035876	SH2D1A, SH2 domain	Domain
A, B, C, D	IPR017289	SH2 protein 1A	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D	Pharos: O60880	lymphoproliferative syndrome X-linked lymphoproliferative disease due to SH2D1A deficiency chronic obstructive pulmonary disease head and neck cancer interstitial cystitis sarcoidosis cutaneous lupus erythematosus hematopoietic and lymphoid system neoplasm lung cancer osteosarcoma Sjogren syndrome X-linked lymphoproliferative syndrome dysgammaglobulinemia hemophagocytic syndrome Lymphoproliferative Disorders lymphoproliferative syndrome X-linked lymphoproliferative disease due to SH2D1A deficiency chronic obstructive pulmonary disease head and neck cancer interstitial cystitis sarcoidosis cutaneous lupus erythematosus hematopoietic and lymphoid system neoplasm lung cancer osteosarcoma Sjogren syndrome X-linked lymphoproliferative syndrome dysgammaglobulinemia hemophagocytic syndrome Lymphoproliferative Disorders psoriasis ulcerative colitis

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.